{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T22:04:41Z","timestamp":1700172281353},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1007\/bf02660785","type":"journal-article","created":{"date-parts":[[2007,7,16]],"date-time":"2007-07-16T21:41:22Z","timestamp":1184622082000},"page":"1719-1720","source":"Crossref","is-referenced-by-count":3,"title":["Safety of botulinum toxin therapies"],"prefix":"10.1097","volume":"46","author":[{"given":"Mariusz H.","family":"Madalinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslaw","family":"Slawek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"BF02660785_CR1","doi-asserted-by":"crossref","first-page":"4l9","DOI":"10.1007\/s10350-004-7296-4","volume":"46","author":"D Brisinda","year":"2003","unstructured":"Brisinda D, Maria G, Fenici R, Civello IM, Brisinda G. Safety of botulinum neurotoxin treatment in patients with chronic anal fissure. Dis Colon Rectum 2003;46:4l9\u201320.","journal-title":"Dis Colon Rectum"},{"key":"BF02660785_CR2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00384-002-0398-3","volume":"17","author":"WH. Jost","year":"2002","unstructured":"Jost WH. Ten years\u2019 experience with botulin toxin in anal fissure. Int J Colorectal Dis 2002;17:298\u2013302.","journal-title":"Int J Colorectal Dis"},{"key":"BF02660785_CR3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/00042737-200208000-00007","volume":"14","author":"M Madalinski","year":"2002","unstructured":"Madalinski M, Slawek J, Duzynski W,et al. Side effects of botulinum toxin injection for benign anal disorders. Eur J Gastroenterol Hepatol 2002; 14:853\u20136.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BF02660785_CR4","first-page":"R17","volume":"2)","author":"D Dressler","year":"(Suppl","unstructured":"Dressler D, Benecke R.: Autonomie side effects after botulinum toxin type B (NeuroBloc). Naunyn-Schmiedeberg\u2019s Arch Pharmacol 2002;365 (Suppl. 2):R17.","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol 2002;365"},{"key":"BF02660785_CR5","first-page":"977","volume":"48","author":"M Madalinski","year":"2001","unstructured":"Madalinski M, Slawek J, Zbytek B,et al. Topical nitrates and the higher doses of botulinum toxin for chronic anal fissure. Hepatogastroenterology 2001;48:977\u20139.","journal-title":"Hepatogastroenterology"},{"key":"BF02660785_CR6","first-page":"103","volume-title":"Scientific and therapeutic aspects of botulinum toxin","author":"KR. Aoki","year":"2002","unstructured":"Aoki KR. Immunologie and other properties of therapeutic botulinum toxin serotypes. In: Brin MF, Hallett M, Jankovic J, eds. Scientific and therapeutic aspects of botulinum toxin. 1st ed. Philadelphia: Lippincott Williams & Wilkins 2002:103\u201313.","edition":"1st ed."},{"key":"BF02660785_CR7","doi-asserted-by":"crossref","first-page":"144l","DOI":"10.1161\/01.CIR.95.6.1441","volume":"95","author":"M Pagani","year":"1997","unstructured":"Pagani M, Montano N, Porta A,et al. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation 1997;95:144l-8.","journal-title":"Circulation"},{"key":"BF02660785_CR8","first-page":"36l","volume":"46","author":"I Lindsey","year":"2003","unstructured":"Lindsey I, Jones OM, Cunningham C, George BD, Mortensen NJ. Botulinum toxin as second-line therapy for chronic anal fissure failing 0.2 percent glyceryl trinitrate. Dis Colon Rectum 2003;46:36l-6.","journal-title":"Dis Colon Rectum"},{"key":"BF02660785_CR9","first-page":"1701","volume":"34l","author":"AM. Kaiser","year":"1999","unstructured":"Kaiser AM. A comparison of botulinum toxin and nitroglycerin ointment for chronic anal fissure [letter]. N Engl J Med 1999;34l:1701.","journal-title":"N Engl J Med"},{"key":"BF02660785_CR10","first-page":"1701","volume":"341","author":"JD. Vogel","year":"1999","unstructured":"Vogel JD. A comparison of botulinum toxin and nitroglycerin ointment for chronic anal fissure [letter]. N Engl J Med 1999;341:1701.","journal-title":"N Engl J Med"},{"key":"BF02660785_CR11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1067\/msy.2002.119314","volume":"131","author":"G Brisinda","year":"2002","unstructured":"Brisinda G, Maria G, Sganga G, Bentivoglio AR, Albanese- A, Castagneto M. Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures. Surgery 2002;131:179\u201384.","journal-title":"Surgery"}],"container-title":["Diseases of the Colon & Rectum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1007\/BF02660785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T16:24:08Z","timestamp":1620923048000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003453-200346120-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.1007\/bf02660785","relation":{},"ISSN":["0012-3706"],"issn-type":[{"value":"0012-3706","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}